ANCA-associated vasculitis (AAV) in the elderly: clinical presentation, treatment and outcomes

被引:0
作者
Gillian McVay
Lucy McGeoch
George W. Chalmers
机构
[1] Glasgow Royal Infirmary,Respiratory Department
[2] Glasgow Royal Infirmary,Rheumatology Department
来源
European Geriatric Medicine | 2018年 / 9卷
关键词
ANCA vasculitis; Geriatric pharmacology; Drug appropriateness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:725 / 728
页数:3
相关论文
共 26 条
[1]  
Watts RA(2000)Epidemiology of systemic vasculitis: a ten year study in the United Kingdom Arthritis Rheumatol 43 414-419
[2]  
Lane SE(2009)Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa Rheumatology (Oxf) 48 1560-1565
[3]  
Bentham G(2005)ANCA-associated renal vasculitis at the end of the twentieth century—a disease of older patients Rheumatology 44 495-501
[4]  
Mohammad AJ(2015)Outcome and treatment of elderly patients with ANCA-associated vasculits Clin J Am Soc Nephrol 10 1128-1135
[5]  
Jacobsson LT(2008)Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients Medicine (Baltim) 87 203-209
[6]  
Westman KW(2010)Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 221-232
[7]  
Harper L(2010)Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 211-220
[8]  
Savage CO(2015)Rituximab for remission induction in elderly patients with ANCA-associated vasculitis Semin Arthritis Rheum 45 67-69
[9]  
Weiner M(2011)ANCA-associated glomerulonephritis in the very elderly Kidney Int 79 757-764
[10]  
Mein Goh S(undefined)undefined undefined undefined undefined-undefined